EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSMMDG00005009408
Gene Symbol: ITGB6
1 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSMMDG00005010894
Gene Symbol: ITGB8
1 Cross references
202 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSMMDG00005012923
Gene Symbol: ITGA5
1 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSMMDG00005003902
Gene Symbol: ITGAV
1 Cross references
237 Possible Orthologues:

Interleukin-1 Receptor-Associated Kinase 4

Ensembl ID : ENSMMDG00005001094
Gene Symbol: IRAK4
1 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSMMDG00005012549
Gene Symbol: LOC115360877
2 Cross references
183 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSMMDG00005024964
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSMMDG00005000828
Gene Symbol: LOC115361082
3 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial-Like

Ensembl ID : ENSMMDG00005019031
Gene Symbol: LOC115379109
3 Cross references
186 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSMMDG00005024863
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSMMDG00005021797
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSMMDG00005009136
Gene Symbol: KIF11
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).